Tetraphase Pharmaceuticals, Inc. announced the appointment of Gerri Henwood, President and Chief Executive Officer of Recro Pharma, to the company's Board of Directors. Ms. Henwood brings more than 30 years' experience in product commercialization, clinical development and regulatory approval processes to the Board. She replaces Steven Gullans, co-founder and partner of Excel Venture Fund.

Ms. Henwood currently serves as President and Chief Executive Officer and Director of Recro Pharma. Ms. Henwood currently serves on the board of two private companies and was previously a member of the board of directors of MAP Pharmaceuticals, Inc. and Alkermes plc.